EXELIXIS INC's ticker is EXEL and the CUSIP is 30161Q104. A total of 365 filers reported holding EXELIXIS INC in Q1 2022. The put-call ratio across all filers is 0.42 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $27,466 | -51.5% | 1,257 | -57.5% | 0.00% | – |
| Q2 2023 | $56,585 | +4.8% | 2,961 | +6.5% | 0.00% | – |
| Q1 2023 | $53,979 | +25.0% | 2,781 | +3.3% | 0.00% | – |
| Q4 2022 | $43,196 | +8.0% | 2,693 | +7.4% | 0.00% | – |
| Q3 2022 | $40,000 | +66.7% | 2,508 | +121.2% | 0.00% | – |
| Q2 2022 | $24,000 | -4.0% | 1,134 | +5.7% | 0.00% | – |
| Q1 2022 | $25,000 | +13.6% | 1,073 | -11.2% | 0.00% | – |
| Q4 2021 | $22,000 | +1000.0% | 1,209 | +1109.0% | 0.00% | – |
| Q3 2021 | $2,000 | -83.3% | 100 | -84.0% | 0.00% | – |
| Q2 2021 | $12,000 | -7.7% | 625 | +6.8% | 0.00% | – |
| Q1 2021 | $13,000 | -7.1% | 585 | -12.4% | 0.00% | – |
| Q4 2020 | $14,000 | -92.0% | 668 | -90.7% | 0.00% | – |
| Q3 2020 | $175,000 | -20.1% | 7,151 | -22.4% | 0.00% | -100.0% |
| Q2 2020 | $219,000 | +34.4% | 9,214 | -2.2% | 0.00% | 0.0% |
| Q1 2020 | $163,000 | -13.3% | 9,424 | -11.9% | 0.00% | 0.0% |
| Q4 2019 | $188,000 | -5.5% | 10,698 | -4.8% | 0.00% | 0.0% |
| Q3 2019 | $199,000 | -12.7% | 11,242 | +5.2% | 0.00% | 0.0% |
| Q2 2019 | $228,000 | -23.2% | 10,690 | -14.3% | 0.00% | 0.0% |
| Q1 2019 | $297,000 | +21.7% | 12,481 | +0.6% | 0.00% | 0.0% |
| Q4 2018 | $244,000 | +8.4% | 12,403 | -2.6% | 0.00% | 0.0% |
| Q3 2018 | $225,000 | +136.8% | 12,735 | +188.5% | 0.00% | 0.0% |
| Q2 2018 | $95,000 | +90.0% | 4,414 | +96.9% | 0.00% | – |
| Q1 2018 | $50,000 | -30.6% | 2,242 | -5.2% | 0.00% | – |
| Q4 2017 | $72,000 | – | 2,366 | +11730.0% | 0.00% | – |
| Q2 2017 | $0 | -100.0% | 20 | -55.6% | 0.00% | – |
| Q4 2016 | $1,000 | -75.0% | 45 | -91.0% | 0.00% | – |
| Q2 2016 | $4,000 | -66.7% | 500 | -82.8% | 0.00% | – |
| Q1 2016 | $12,000 | +9.1% | 2,913 | 0.0% | 0.00% | – |
| Q2 2015 | $11,000 | +22.2% | 2,913 | -14.6% | 0.00% | – |
| Q1 2015 | $9,000 | +28.6% | 3,413 | -33.5% | 0.00% | – |
| Q4 2014 | $7,000 | -46.2% | 5,131 | -38.4% | 0.00% | – |
| Q3 2014 | $13,000 | -53.6% | 8,324 | 0.0% | 0.00% | -100.0% |
| Q2 2014 | $28,000 | +16.7% | 8,324 | +21.4% | 0.00% | 0.0% |
| Q1 2014 | $24,000 | -20.0% | 6,854 | +41.4% | 0.00% | 0.0% |
| Q4 2013 | $30,000 | +7.1% | 4,846 | 0.0% | 0.00% | 0.0% |
| Q3 2013 | $28,000 | +27.3% | 4,846 | 0.0% | 0.00% | 0.0% |
| Q2 2013 | $22,000 | – | 4,846 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 15,001,073 | $265,294,000 | 64.62% |
| Sargent Investment Group, LLC | 465,620 | $8,234,000 | 3.70% |
| Orbimed Advisors | 3,912,900 | $69,200,000 | 1.31% |
| Bellevue Group AG | 3,858,700 | $68,241,000 | 1.27% |
| TEALWOOD ASSET MANAGEMENT INC | 137,129 | $2,425,000 | 1.04% |
| CAPITAL MANAGEMENT CORP /VA | 200,995 | $3,555,000 | 0.97% |
| Penn Capital Management Company, LLC | 517,988 | $9,161,000 | 0.96% |
| Chicago Capital, LLC | 801,560 | $14,176,000 | 0.95% |
| Portolan Capital Management | 454,444 | $8,037,000 | 0.91% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 103,534 | $1,830,000 | 0.85% |